The Latest Breaking News from FDA

As I’ve grown older and experienced the vagaries of my ageing memory, I’ve often reflected on the possibility of a miracle cure that would rejuvenate it. As if in answer to my wishful thinking, not one but several reports recently appeared simultaneously in the scientific news, highlighting a trending solution…

The new drug will be many times more expensive than a standard opioid option

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out of foods and drugs.

The industry ties and policy backgrounds of these officials and cabinet nominees are varied – and often contradictory

Suzetrigine, a new non-opioid pain relief drug sold under the brand name Journavx marks the first new class of pain reliever to receive FDA approval in over two decades.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids

"The cultivated meat industry hopes a pro-business argument can win over skeptical Republicans"

Tonix Pharmaceuticals' innovative approach to fibromyalgia treatment positions the company for substantial market disruption and long-term growth.

A major chocolate recall has been upgraded due to undeclared milk posing serious health risks for allergy sufferers.

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the constitutional right to abortion, according to an October 2024 study.

Robert F